Home

inventar Megalópolis balsa claude bertrand servier Sumergir distrito Aeródromo

Our Team - Abivax
Our Team - Abivax

Intervention Claude Bertrand - Journée Responsable - YouTube
Intervention Claude Bertrand - Journée Responsable - YouTube

Servier : Claude Bertrand est nommé directeur général de la R&D- AEFinfo
Servier : Claude Bertrand est nommé directeur général de la R&D- AEFinfo

MaaT Pharma Appoints Claude Bertrand, Servier's Executive Vice President of  R&D, as Independent Board Member and Welcomes New Chief Medical Officer  John Weinberg | Business Wire
MaaT Pharma Appoints Claude Bertrand, Servier's Executive Vice President of R&D, as Independent Board Member and Welcomes New Chief Medical Officer John Weinberg | Business Wire

News
News

French pharma company Servier tabs Montreal for new AI hub
French pharma company Servier tabs Montreal for new AI hub

Grandeur et décadence du docteur Servier - Challenges
Grandeur et décadence du docteur Servier - Challenges

Our Team - Abivax
Our Team - Abivax

Claude Bertrand - United Kingdom | Professional Profile | LinkedIn
Claude Bertrand - United Kingdom | Professional Profile | LinkedIn

Scientific Advisory Committee | Institut du Médicament de Strasbourg
Scientific Advisory Committee | Institut du Médicament de Strasbourg

Servier (@Servier) / Twitter
Servier (@Servier) / Twitter

Servier on Twitter: "We are always exploring different ways to serve  patients' needs. This includes #research & #development of monoclonal  antibodies to fight against #cancer. Learn more about our latest  announcements👉https://t.co/Q84thhbOsh https://t ...
Servier on Twitter: "We are always exploring different ways to serve patients' needs. This includes #research & #development of monoclonal antibodies to fight against #cancer. Learn more about our latest announcements👉https://t.co/Q84thhbOsh https://t ...

News
News

Servier (@Servier) / Twitter
Servier (@Servier) / Twitter

Ivosidenib/Azacitidine Significantly Improves EFS in Previously Untreated  IDH1-Mutated AML
Ivosidenib/Azacitidine Significantly Improves EFS in Previously Untreated IDH1-Mutated AML

Claude Bertrand - United Kingdom | Professional Profile | LinkedIn
Claude Bertrand - United Kingdom | Professional Profile | LinkedIn

Servier in oncology: bringing innovation to patients - Servier
Servier in oncology: bringing innovation to patients - Servier

1 2-3 4-5 6-7 8-9 10-11 12-13 14-15 16-17 18-19 20-21 22-23 24-25 26-27  28-29 30-31 32 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Close Cookies  management panel When you visit the “servier.com” website, cookies are  placed on your browser. Your ...
1 2-3 4-5 6-7 8-9 10-11 12-13 14-15 16-17 18-19 20-21 22-23 24-25 26-27 28-29 30-31 32 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Close Cookies management panel When you visit the “servier.com” website, cookies are placed on your browser. Your ...

Claude Bertrand's email & phone | Servier's Executive Vice President R and  D, Chief Scientific Officer email
Claude Bertrand's email & phone | Servier's Executive Vice President R and D, Chief Scientific Officer email

Claude Bertrand's email & phone | Servier's Executive Vice President R and  D, Chief Scientific Officer email
Claude Bertrand's email & phone | Servier's Executive Vice President R and D, Chief Scientific Officer email

Mediator : la face cachée de Jacques Servier
Mediator : la face cachée de Jacques Servier

2022 Drug Discovery Conference | Stanford Cardiovascular Institute |  Stanford Medicine
2022 Drug Discovery Conference | Stanford Cardiovascular Institute | Stanford Medicine